前海健康(00911.HK)附屬收到法院發出的舉證通知書
格隆匯5月13日丨前海健康(00911.HK)發佈公吿,2024年5月6日,公司一家附屬公司收到北京市第四中級人民法院於2024年4月17日發出的舉證通知書(“通知書”)。該主體事項涉及公司全資附屬公司志成偉業有限公司(“志成偉業”)的一名供應商(“供應商”)、志成偉業及公司的合約糾紛,內容有關指控未履行若干採購合約及擔保函的付款義務。
所指控的申索與志成偉業於2022年6月及7月期間向供應商下達的若干電子零件採購訂單有關。佔採購價格20%的按金已支付,所指控金額為志成偉業向集團交付產品前應支付的採購價格結餘。
有關採購合約項下的交易及相關延遲履行採購責任的資料已於公司2023年年報的綜合財務報表附註披露,而集團當時已解釋導致截至2022年12月31日止年度計提虧損合約撥備約9300萬港元的情況。
訂立相關採購合約時,相關產品以低於當時市場價格的價格採購。然而,於採購後,由於相關電子零件產品的市場價格呈下降趨勢,志成偉業認為將先前以較高採購價格購買的相關電子零件產品收貨並以較低的售價出售不符合公司的最佳利益。因此,志成偉業暫時停止根據採購合約完成相關產品的採購(包括支付採購價格的結餘及收貨)。
與指控相反,集團不時與供應商就付款及接收產品的時間安排進行討論。截至2023年12月31日止年度及直至本公佈日期,公司就相關採購合約支付合共約1400萬美元的結餘款項;而供應商已向集團交付與公司所付結餘款項相應數量的產品;且該等產品的部分已出售給集團的客户。
在收到通知書後及直至本公佈日期,公司一直積極與供應商聯繫,解決合約糾紛及達成和解。與此同時,集團正就中華人民共和國法律向其法律顧問尋求法律意見,如有必要,將積極應對訴訟。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.